Replies to post #132504 on Biotech Values

[DewDiligence]

NGNM—The co. is close to being ready for NASDAQ small market listing, which will go a long way towards further recognition as a legitimate and tradable co.

What still needs to be done for the Nasdaq listing to take effect?

One personal sign of this (for me at least) is that my personal contact with Steve Jones, one of the co. principles and IR relations, has stopped communicating with me, suggesting that he has graduated from the need to visit with individual investors and is focused on the bigger picture.

An astute, albeit cynical, observation. In my experience, biotech companies that are unduly solicitous of support from small-time investors are more likely than not to end up being failures.